Patents by Inventor Ming Shi

Ming Shi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for Vernier ring time to digital converter with self-delay ratio calibration
    Patent number: 8976053
    Abstract: Some embodiments of the present invention provide a method and apparatus for a Vernier ring time to digital converter having a single clock input and an all digital circuit that calculates a fixed delay relationship between a set of slow buffers and fast buffers. A method for calibrating a Vernier Delay Line of a TDC, comprising the steps of inputting a reference clock to a slow buffer and to a fast buffer, determining a delay ratio of the slow buffer and fast buffer; and adjusting the delay ratio of the slow buffer and fast buffer to a fixed delay ratio value wherein an up-down accumulator generates control signals to adjust the slow buffer.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: March 10, 2015
    Assignee: Amlogic Co., Ltd.
    Inventors: Weicheng Zhang, Ming Shi, Wei-Hua Zou, Shu-Sun Yu, Chieh-Yuan Chao
  • Termination circuit and DC balance method thereof
    Patent number: 8952718
    Abstract: A termination circuit for a plurality of memories controlled by a controller is provided. The termination circuit includes a plurality of drivers, a plurality of resistors and a plurality of capacitors. Each of the drivers is coupled to the memories via a transmission line. Each of the resistors is coupled to the corresponding driver via the corresponding transmission line. Each of the capacitors is coupled between the corresponding resistor and a reference voltage. The controller is coupled to the memories via the drivers, and the controller provides a specific code to one of the drivers when a quantity of logic “0” and a quantity of logic “1” transmitted to the memories via the transmission line corresponding to the one of the drivers are unbalanced, so as to adjust a termination voltage of the capacitor corresponding to the one of the drivers.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: February 10, 2015
    Assignee: Mediatek Inc.
    Inventors: Yan-Bin Luo, Sheng-Ming Chang, Bo-Wei Hsieh, Ming-Shi Liou, Chih-Chien Hung, Shang-Ping Chen
  • USE OF IL-20 ANTAGONISTS FOR ALLEVIATING OBESITY
    Publication number: 20140370014
    Abstract: Alleviating obesity in a subject (e.g., a human subject) having, being suspected of having, or at risk for obesity using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
    Type: Application
    Filed: June 17, 2014
    Publication date: December 18, 2014
    Applicant: National Cheng Kung University
    Inventors: Ming-Shi Chang, Yu-Hsiang Hsu
  • USE OF IL-20 ANTAGONISTS FOR ALLEVIATING SPINAL CORD INJURY
    Publication number: 20140370015
    Abstract: Alleviating neural injury, such as spinal cord injury, in a subject (e.g., a human subject) in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
    Type: Application
    Filed: June 17, 2014
    Publication date: December 18, 2014
    Applicant: National Cheng Kung University
    Inventors: Ming-Shi Chang, I-Ming Jou
  • Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity
    Patent number: 8911730
    Abstract: The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: December 16, 2014
    Assignee: Amgen Inc.
    Inventors: Chris Saris, Ming-Shi Chang
  • Fan control system using a microcontroller
    Patent number: 8905721
    Abstract: A fan control system. The fan control system has a programmable microcontroller to receive an input signal and a rotation speed signal corresponding to the actual rotation speed of the fan motor, determining an output signal according to the input signal and the rotation speed signal, and outputting the output signal; and a fan-driving unit to receive the output signal and adjusting the rotation speed for driving the fan motor according to the output signal. The rotation speed is in a relation of a multi-stage function to the input signal.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: December 9, 2014
    Assignee: Delta Electronics Inc.
    Inventors: Wen-Chuan Ma, Pou-Tsun Kuo, Ming-Shi Tsai, Wen-Shi Huang
  • ACTIVE OUTPUT BUFFER CONTROLLER FOR CONTROLLING PACKET DATA OUTPUT OF MAIN BUFFER IN NETWORK DEVICE AND RELATED METHOD
    Publication number: 20140321473
    Abstract: An active output buffer controller is used for controlling a packet data output of a main buffer in a network device. The active output buffer controller has a credit evaluation circuit and a control logic. The credit evaluation circuit estimates a credit value based on at least one of an ingress data reception status of the network device and an egress data transmission status of the network device. The control logic compares the credit value with a first predetermined threshold value to generate a comparison result, and controls the packet data output of the main buffer according to at least the comparison result.
    Type: Application
    Filed: March 31, 2014
    Publication date: October 30, 2014
    Applicant: MEDIATEK INC.
    Inventors: Yu-Hsun Chen, Yi-Hsin Yu, Ming-Shi Liou, Ming Zhang
  • Treating allergic airway disorders using anti-IL-20 receptor antibodies
    Patent number: 8852588
    Abstract: Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.
    Type: Grant
    Filed: August 7, 2012
    Date of Patent: October 7, 2014
    Assignee: National Cheng Kung University
    Inventor: Ming-Shi Chang
  • ANGLE DETECTING MODULE AND METHOD FOR MOTOR ROTOR
    Publication number: 20140210390
    Abstract: An angle detecting module for a motor rotor is provided. The angle detecting module includes a permanent-magnet synchronous motor, three linear hail components and a processing device. The permanent-magnet synchronous motor includes a stator and a rotor. The three linear hall components are disposed on the stator; and the linear hall components are spaced by electrical 120 degrees. Each of the linear hall components outputs an analog signal after measuring a magnetic field, position of the rotor, and each of the analog signals has magnetically saturated third harmonic component. The processing device is electrically connected to the linear hall components, and the processing device optimizes each of the analog signals and generates an average rotor angle.
    Type: Application
    Filed: January 1, 2014
    Publication date: July 31, 2014
    Applicant: RHYMEBUS CORPORATION
    Inventors: Ming-Shi HUANG, Hung-Hsing CHIANG, Ming-Chang CHOU, Cheng-Ching CHANG
  • Use of IL-20 Antagonists for Treating Liver Diseases
    Publication number: 20140120094
    Abstract: Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
    Type: Application
    Filed: October 30, 2013
    Publication date: May 1, 2014
    Applicant: National Cheng Kung University
    Inventor: Ming-Shi Chang
  • USE OF IL-20 ANTAGONISTS FOR PROMOTING BONE FRACTURE HEALING
    Publication number: 20140065144
    Abstract: Promoting bone fracture healing in a subject having a bone fracture using an IL-20 antagonist, which can be an antibody that blocks an IL-20-mediated signaling pathway. Such antibodies include anti-IL-20 antibodies and anti-IL-20R1 antibodies capable of blocking the IL-20-mediated signaling pathway.
    Type: Application
    Filed: August 30, 2012
    Publication date: March 6, 2014
    Applicant: National Cheng Kung University
    Inventor: Ming-Shi Chang
  • Humanized Anti-IL-20 Antibody And Uses Thereof
    Publication number: 20140056886
    Abstract: Humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.
    Type: Application
    Filed: October 29, 2013
    Publication date: February 27, 2014
    Applicant: NATIONAL CHENG KUNG UNIVERSITY
    Inventor: Ming-Shi Chang
  • TREATING ALLERGIC AIRWAY DISORDERS USING ANTI-IL-20 RECEPTOR ANTIBODIES
    Publication number: 20140044715
    Abstract: Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.
    Type: Application
    Filed: August 7, 2012
    Publication date: February 13, 2014
    Applicant: National Cheng Kung University
    Inventor: Ming-Shi Chang
  • Treatment of Osteoarthritis Using IL-20 Antagonists
    Publication number: 20140023648
    Abstract: Methods for alleviating or delaying the onset of osteoarthritis in a subject in need of the treatment using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20, e.g., an anti-IL-20 antibody.
    Type: Application
    Filed: July 18, 2013
    Publication date: January 23, 2014
    Inventor: MING-SHI CHANG
  • Use of IL-20 antagonists for treating liver diseases
    Patent number: 8603470
    Abstract: Reducing liver fibrosis in a subject having or being suspected of having a liver disease using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
    Type: Grant
    Filed: August 7, 2012
    Date of Patent: December 10, 2013
    Assignee: National Cheng Kung University
    Inventor: Ming-Shi Chang
  • Humanized anti-IL-20 antibody and uses thereof
    Patent number: 8597647
    Abstract: The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: December 3, 2013
    Assignee: National Cheng Kung University
    Inventors: Ming-Shi Chang, Naoya Tsurushita, Shankar Kumar
  • HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF
    Publication number: 20130315893
    Abstract: The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.
    Type: Application
    Filed: May 22, 2012
    Publication date: November 28, 2013
    Applicant: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: Ming-Shi CHANG, Naoya Tsurushita, Shankar Kumar
  • Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
    Patent number: 8535674
    Abstract: Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: September 17, 2013
    Assignee: National Cheng Kung University
    Inventor: Ming-Shi Chang
  • Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
    Patent number: 8454956
    Abstract: The invention features methods and compositions for preventing or treating rheumatoid arthritis and osteoporosis by administering an antagonist of IL-20. The IL-20 antagonist may be an anti-IL-20 antibody, such as mAB 7E, that is capable of binding human IL-20 and blocking IL-20 interaction with its receptors.
    Type: Grant
    Filed: August 26, 2010
    Date of Patent: June 4, 2013
    Assignee: National Cheng Kung University
    Inventor: Ming-Shi Chang
  • TERMINATION CIRCUIT AND DC BALANCE METHOD THEREOF
    Publication number: 20130113516
    Abstract: A termination circuit for a plurality of memories controlled by a controller is provided. The termination circuit includes a plurality of drivers, a plurality of resistors and a plurality of capacitors. Each of the drivers is coupled to the memories via a transmission line. Each of the resistors is coupled to the corresponding driver via the corresponding transmission line. Each of the capacitors is coupled between the corresponding resistor and a reference voltage. The controller is coupled to the memories via the drivers, and the controller provides a specific code to one of the drivers when a quantity of logic “0” and a quantity of logic “1” transmitted to the memories via the transmission line corresponding to the one of the drivers are unbalanced, so as to adjust a termination voltage of the capacitor corresponding to the one of the drivers.
    Type: Application
    Filed: August 10, 2012
    Publication date: May 9, 2013
    Applicant: MEDIATEK INC.
    Inventors: Yan-Bin LUO, Sheng-Ming CHANG, Bo-Wei HSIEH, Ming-Shi LIOU, Chih-Chien HUNG, Shang-Ping CHEN